Showing results (511-520 of 628) with videos related to
Sort By:
Pageof 63
Experimental Neurology|March 21, 2007
Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD miceRhonda L Nelson, Zhihong Guo, Veerendra Madala Halagappa, et al.Journal of Neurochemistry|April 10, 2008
Modulation of taste sensitivity by GLP-1 signalingYu-Kyong Shin, Bronwen Martin, Erin Golden, et al.Experimental Neurology|July 1, 2008
Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenalSung-Chun Tang, Justin D Lathia, Pradeep K Selvaraj, et al.Journal of Alzheimer'S Disease : JAD|September 18, 2010
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's diseaseDong Liu, Michael Pitta, Jong-Hwan Lee, et al.Journal of Neurochemistry|March 21, 2002
A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78Yongquan Luo, Jeffery M Long, Chengbiao Lu, et al.Experimental Neurology|November 18, 2008
Diminished iron concentrations increase adenosine A(2A) receptor levels in mouse striatum and cultured human neuroblastoma cellsSeema Gulyani, Christopher J Earley, Simonetta Camandola, et al.Vaccine|January 18, 2012
DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's diseasePurevdorj B Olkhanud, Mohammed Mughal, Koichi Ayukawa, et al.Neuromolecular Medicine|April 1, 2003
Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine developmentAvindra Nath, Elizabeth Hall, Marnia Tuzova, et al.Neuron|February 15, 2011
Activity-induced Notch signaling in neurons requires Arc/Arg3.1 and is essential for synaptic plasticity in hippocampal networksLavinia Alberi, Shuxi Liu, Yue Wang, et al.The Journal of Pharmacology and Experimental Therapeutics|May 26, 2010
Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptidesByung-Joon Kim, Jie Zhou, Bronwen Martin, et al.Pageof 63